Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mission LISA Foundation is a non-profit patient advocacy organization dedicated to finding a cure for Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A), also known as Calpainopathy. The foundation focuses on funding and accelerating the development of transformative treatments, with a particular emphasis on gene therapy approaches designed to restore the function of the CAPN3 gene. By collaborating with world-renowned scientists and academic institutions, Mission LISA aims to bridge the gap between laboratory research and clinical trials for this rare neuromuscular disorder. The organization also works to raise global awareness and provide support for families affected by LGMD2A.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mission LISA Foundation.